M. Kuwagata et al., A COMPARISON OF THE IN-VIVO AND IN-VITRO RESPONSE OF RAT EMBRYOS TO 5-FLUOROURACIL, Journal of veterinary medical science, 60(1), 1998, pp. 93-99
This study serves to further define the capabilities of the whole embr
yo culture system using the well-known teratogen, 5-fluorouracil (5-FU
), an antineoplastic agent. An initial in vivo study was performed whe
reby pregnant rats were injected intraperitoneally with 10-30 mg/kg 5-
FU on day 9 of gestation. On day 20 of gestation, the effects of this
drug on the growth and development of embryos were evaluated. The numb
er of externally malformed fetuses increased in a dose-related manner,
and the most common defect was micro-/anophthalmos in fetuses of dams
treated with 5-FU. Growth retardation was also noted in the 5-FU trea
ted groups. An in vitro study was performed in which drug concentratio
ns were varied (0.15-0.30 mu g/ml). Externally abnormal embryos were o
bserved in whole embryo culture system from embryonic day 9 to 11. The
most common defect was hypoplastic optic vesicles. ln the whole embry
o culture system, crown-rump length, somite number, protein contents,
and morphological score were decreased in a dose-dependent fashion. Fi
nally, histological evaluation and observation of the pattern of cell
death of the optic vesicle of ii-day-old embryos in in vivo and in vit
ro were performed. These parameters revealed no differences in respons
e between in vivo and in vitro embryos treated with 5-FU, suggesting t
hat the whole embryo culture system was an appropriate model for devel
opmental toxicity studies of 5-FU.